Real Brands, Inc. (RLBD) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Real Brands, Inc. (RLBD) trades at $0.00001. Real Brands, Inc. specializes in the extraction and wholesale of hemp-derived CBD products, including oils and topical applications. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for RLBD: RLBD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RLBD against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RLBD: 1/3 scored disciplines lean bearish. Dominant signal: Ken Griffin bearish.
How is this calculated? →Real Brands, Inc. (RLBD) Healthcare & Pipeline Overview
Real Brands, Inc. is a healthcare company focused on the extraction and wholesale of hemp-derived CBD products, positioning itself in a rapidly expanding market with a diverse product range including oils, creams, and capsules.
What Is the Investment Thesis for RLBD?
Real Brands, Inc. is positioned in the rapidly growing CBD market, which is projected to reach $13.4 billion by 2028, growing at a CAGR of 21.2%. The company’s diverse product line, including topical creams, oils, and capsules, provides multiple revenue streams. However, the current financial metrics indicate challenges, including a profit margin of -2203.4% and a gross margin of -41.6%, highlighting the need for operational improvements. The company’s focus on quality extraction processes and compliance with regulatory standards could serve as a competitive advantage in a fragmented market. Investors may want to evaluate the potential for growth against the backdrop of ongoing financial challenges.
Based on FMP financials and quantitative analysis
RLBD Key Highlights
Market Cap: $0.00B, indicating a current lack of market valuation.
- P/E Ratio: -0.02, suggesting negative earnings.
- Profit Margin: -2203.4%, highlighting significant operational losses.
- Gross Margin: -41.6%, reflecting challenges in cost management.
- Beta: 0.93, indicating lower volatility compared to the market.
Who Are RLBD's Competitors?
RLBD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RLBD's Key Strengths?
Established presence in the growing CBD market.
- Diverse product offerings catering to various consumer segments.
- Expertise in extraction and product formulation.
What Are RLBD's Weaknesses?
Limited workforce, currently employing only one individual.
- Negative profit margins indicating operational challenges.
- Lack of market cap suggests low investor confidence.
What Could Drive RLBD Stock Higher?
Expansion of product line to include new CBD formulations.
- Increasing consumer demand for natural wellness products.
- Development of strategic partnerships for distribution.
- Potential regulatory changes favoring CBD products.
- Focus on improving operational efficiency to enhance margins.
What Are the Key Risks for RLBD?
Financial-distress signal — its Altman Z-Score of -20.68 sits in the distress zone (elevated bankruptcy risk).
- Insider selling — insiders were net sellers of roughly $1.6M recently.
- Regulatory changes that could impact product sales.
- Intense competition from established CBD brands.
- Financial instability due to negative profit margins.
- Shifts in consumer preferences away from CBD products.
What Are the Growth Opportunities for RLBD?
- Growth opportunity 1: The global CBD market is projected to reach $13.4 billion by 2028, growing at a CAGR of 21.2%. Real Brands can capitalize on this growth by expanding its product line and increasing distribution channels, particularly in regions where CBD regulations are becoming more favorable.
- Growth opportunity 2: The increasing trend towards natural wellness products presents an opportunity for Real Brands to enhance its marketing efforts around the health benefits of CBD. By targeting health-conscious consumers and leveraging social media, the company can increase brand awareness and customer loyalty.
- Growth opportunity 3: Real Brands could explore partnerships with retailers and e-commerce platforms to broaden its market reach. Collaborations with established brands in the health and wellness sector could provide additional credibility and access to a larger customer base.
- Growth opportunity 4: The development of new product formulations, such as innovative delivery methods or targeted therapeutic applications, could set Real Brands apart from competitors. Investing in research and development can lead to unique offerings that meet specific consumer needs.
- Growth opportunity 5: Expanding into international markets where CBD is gaining acceptance could significantly boost revenue. Identifying regions with favorable regulatory environments and consumer demand will be crucial for successful expansion.
What Opportunities Does RLBD Have?
- Expanding CBD market with significant growth projections.
- Potential for product innovation and new formulations.
- Opportunities for international market expansion.
What Threats Does RLBD Face?
- Intense competition from other CBD producers.
- Regulatory changes that could impact operations.
- Market volatility and shifting consumer preferences.
What Are RLBD's Competitive Advantages?
- Expertise in CBD extraction and product formulation.
- Commitment to quality and compliance with industry regulations.
- Diverse product range catering to various consumer needs.
- Established relationships with suppliers and distributors.
What Does RLBD Do?
Founded in 2011 and headquartered in North Providence, Rhode Island, Real Brands, Inc. engages in the extraction of hemp cannabinol (CBD) oil and isolate. The company operates primarily in the wholesale market, providing a variety of hemp-derived CBD products that cater to diverse consumer needs. Its product offerings include topical creams and gels, cosmetics, tinctures, oils, capsules, vape cartridges, oral sprays, lotions, and other innovative products. Over the years, Real Brands has established itself in the CBD market, which has been experiencing significant growth due to increasing consumer interest in wellness products derived from hemp. The company's commitment to quality and compliance with industry standards positions it as a reliable supplier in the evolving landscape of CBD products. With a small team of just one employee, Real Brands focuses on streamlining operations to maximize efficiency and responsiveness to market demands. As the CBD market continues to expand, Real Brands aims to leverage its expertise in product development and distribution to capture a larger share of this burgeoning industry.
What Products and Services Does RLBD Offer?
- Extracts hemp cannabinol (CBD) oil and isolate.
- Wholesale CBD oils and isolates to various markets.
- Produces and sells a range of hemp-derived CBD products.
- Offers topical creams, gels, and cosmetics infused with CBD.
- Provides tinctures, oils, capsules, and vape cartridges.
- Develops oral sprays and lotions for consumer use.
How Does RLBD Make Money?
- Real Brands generates revenue through the wholesale of CBD oils and isolates.
- The company sells a variety of hemp-derived products directly to consumers and retailers.
- Focuses on product diversification to cater to different consumer preferences and needs.
- Utilizes a streamlined operational model to maintain cost efficiency and responsiveness.
What Industry Does RLBD Operate In?
The drug manufacturing industry, particularly in the specialty and generic sectors, is witnessing a significant shift towards natural and hemp-derived products. The CBD market is expanding rapidly, driven by increasing consumer awareness of health benefits and changing regulations. Real Brands, Inc. operates within this dynamic environment, competing with other companies such as CWWBF, FFNTF, GPFT, HMPQ, and LRSV. As the market size for CBD products is projected to grow substantially, companies that can effectively navigate regulatory landscapes and consumer preferences are likely to gain a competitive edge.
Who Are RLBD's Key Customers?
- Retailers looking to stock CBD products.
- Health-conscious consumers interested in natural wellness solutions.
- Online shoppers seeking convenience in purchasing CBD goods.
- Distributors looking for quality CBD products for resale.
Company Profile
Real Brands, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in North Providence, US. The company is led by CEO Thomas Kidrin. RLBD has traded publicly since 2000.
Key Financial Metrics
Return on equity for Real Brands, Inc. stands at 129.5%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Real Brands, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -20.68 places it in the distress zone, a signal of elevated financial risk.
Insider Activity
The most recent 11 insider filings for Real Brands, Inc. break down as 8 sales and 3 purchases. On net that is roughly 55.8M shares disposed (about $1.6M), a signal worth weighing alongside the fundamentals.
RLBD Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Established presence in the growing CBD market.
- Diverse product offerings catering to various consumer segments.
- Expertise in extraction and product formulation.
- Upcoming: Expansion of product line to include new CBD formulations.
Bear Case
- Limited workforce, currently employing only one individual.
- Negative profit margins indicating operational challenges.
- Lack of market cap suggests low investor confidence.
- Potential: Regulatory changes that could impact product sales.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
RLBD Latest News
No recent news available for RLBD.
RLBD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RLBD.
Price Targets
Wall Street price target analysis for RLBD.
RLBD MoonshotScore
What does this score mean?
The MoonshotScore rates RLBD 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Thomas Kidrin
CEO
Thomas Kidrin has been at the helm of Real Brands, Inc. since its inception in 2011. With a background in business management, he has guided the company through the challenges of the evolving CBD market. His leadership focuses on operational efficiency and product quality, ensuring that Real Brands remains competitive in a rapidly changing industry.
Track Record: Under Kidrin's leadership, Real Brands has developed a diverse product line and established a presence in the CBD market. His strategic decisions have aimed at enhancing product quality and compliance with industry standards, positioning the company for future growth.
RLBD OTC Market Information
The OTC Other tier represents companies that do not meet the requirements for higher tiers like NYSE or NASDAQ. Companies in this tier may have less stringent reporting requirements, leading to potentially lower transparency for investors.
- OTC Tier: OTC Other
- Limited financial reporting and transparency compared to larger exchanges.
- Potential for lower liquidity and higher volatility in stock price.
- Regulatory risks associated with the cannabis and CBD industry.
- Verify the company's financial reports and disclosures.
- Assess the competitive landscape and market positioning.
- Evaluate the regulatory environment for CBD products.
- Investigate the company's operational efficiency and management.
- Review customer feedback and product quality.
- Established presence in the CBD market since 2011.
- Diverse product offerings indicating a commitment to innovation.
- Compliance with industry regulations and standards.
Common Questions About RLBD (Healthcare)
What does Real Brands, Inc. do?
Real Brands, Inc. specializes in the extraction and wholesale of hemp-derived CBD products. The company offers a variety of items including topical creams, oils, tinctures, and capsules, catering to a growing consumer base interested in natural wellness solutions.
What do analysts say about RLBD stock?
Analysts have expressed concerns regarding Real Brands, Inc.'s financial performance, particularly its negative profit margins and lack of market capitalization. However, they note the potential for growth in the CBD market, driven by increasing consumer interest and favorable regulatory trends.
What are the main risks for RLBD?
Real Brands, Inc. faces several risks, including regulatory uncertainties that could impact its ability to market CBD products. Additionally, the company contends with intense competition in the CBD sector and ongoing financial challenges that may hinder its growth prospects.
What are the key factors to evaluate for RLBD?
Evaluate RLBD on fundamentals, analyst consensus, and risk factors. Real Brands, Inc. is positioned in the rapidly growing CBD market, which is projected to reach $13.4 billion by 2028, growing at a CAGR of 21.2%. Not financial advice.
How frequently does RLBD data refresh on this page?
RLBD's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven RLBD's recent stock price performance?
Real Brands, Inc. (RLBD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established presence in the growing CBD market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RLBD overvalued or undervalued right now?
Real Brands, Inc. (RLBD) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research RLBD before investing?
Before investing in Real Brands, Inc. (RLBD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial reporting is limited due to OTC classification; further verification is recommended.